This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB06995/identifier/chemspider/
n11http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB06995/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB06995/identifier/pubchem-compound/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/resource/drugbank/drug/DB06995/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB06995/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06995
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB06995 n11:DB06995
dcterms:title
N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide
adms:identifier
n4:99443466 n7:DB06995 n8:319 n13:22376235 n14:17748441
n5:IUPAC-Name
n6:271B3F3A-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B3F40-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B3F3F-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B3F3C-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B3F3D-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B3F3E-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B3F38-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B3F39-363D-11E5-9242-09173F13E4C5 n6:271B3F36-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B3F37-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B3F46-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B3F47-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B3F41-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B3F42-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B3F44-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B3F43-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B3F45-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B3F4C-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B3F4E-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B3F4F-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B3F4B-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B3F4A-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B3F4D-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B3F3B-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B3F48-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B3F49-363D-11E5-9242-09173F13E4C5